← FDA Drug Approvals (Drugs@FDA)

VELCADE

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2003-05-13

Drug application

FDA Application #

NDA021602

Application type

New Drug Application

Brand name

VELCADE

Generic name

BORTEZOMIB

Active ingredients

BORTEZOMIB

Dosage form

INJECTABLE

Route

INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

Manufacturer

Takeda Pharmaceuticals America, Inc.

First approval

2003-05-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown